Thailand will reportedly cap its exports of domestically-produced AstraZeneca Covid vaccines in a bid to meet its growing demand amid the spike in coronavirus cases.
The National Vaccine Institute (NVI) and Disease Control Department have decided to enforce a quota on the export of Thai-manufactured AstraZeneca Covid-19 vaccine by Siam Bioscience Co (SBC).
This decision will be communicated to the National Vaccine Committee (NVC) for approval. Thailand’s Deputy Prime Minister and Public Health Minister Anutin Charnvirakul, who chairs NVC, may bring out the mandate to enforce the export quota.
The Thai authorities will sit for negotiation with SBC and recommend that it supply the Covid vaccine to Thailand in light of the country’s ongoing pandemic situation. The Southeast Asian nation recorded 9,317 fresh Covid-19 cases, increasing the total infection count in the country to 3, 63,029. The daily infection number has been over 5,000 in July. This is in contrast to the sub-100 infection count in early April when the pandemic’s third wave broke out.